Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Uncertainty and EGFR[original query] |
---|
A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms. The Journal of molecular diagnostics : JMD 2014 Jan 16 (1): 45-55. Beau-Faller Michèle, Blons Hélène, Domerg Caroline, Gajda Dorota, Richard Nicolas, Escande Fabienne, Solassol Jérôme, Denis Marc G, Cayre Anne, Nanni-Metellus Isabelle, Olschwang Sylviane, Lizard Sarab, Piard Fabienne, Pretet Jean-Luc, de Fraipont Florence, Bièche Ivan, de Cremoux Patricia, Rouquette Isabelle, Bringuier Pierre-Paul, Mosser Jean, Legrain Michèle, Voegeli Anne-Claire, Saulnier Patrick, Morin Franck, Pignon Jean-Pierre, Zalcman Gérard, Cadranel Jacqu |
Gene-guided gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive non-small cell lung cancer: an economic analysis. BMC cancer 2013 13 . Zhu J, Li T, Wang X, Ye M, Cai J, Xu Y, Wu B |
External Quality Assurance of Current Technology for the Testing of Cancer-Associated Circulating Free DNA Variants. Pathology oncology research : POR 2019 9 26 (3): 1595-1603. Chai Sze Yee, Peng Rongxue, Zhang Rui, Zhou Li, Pillay Nalishia, Tay Kwang Hong, Badrick Tony, Li Jinming, Horan Martin |
- Page last reviewed:Feb 1, 2024
- Content source: